NCT03772197View on ClinicalTrials.gov

Parallel Comparison of 18 Gene Classifiers and Oncotype DX (Nanostring)

CompletedOBSERVATIONAL

Enrollment

138

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

October 18, 2018

Study Completion Date

November 1, 2018

Conditions

Breast CancerRecurrence

Trial Locations (1)

106

Amwise, Taipei

All Listed Sponsors

lead

Amwise Diagnostics Pte. Ltd.

INDUSTRY

NCT03772197 - Parallel Comparison of 18 Gene Classifiers and Oncotype DX (Nanostring) | Biotech Hunter | Biotech Hunter